MIRM · NASDAQ · Biotechnology

Mirum Pharmaceuticals

Commercializes rare-disease medicines while building a broader liver and genetic-disease pipeline.

$97.46
After-hours close0.00 (0.00%)
At close$97.46(−2.30%)
DateEstimateReportedSurprise
Nov 2026−$0.53
Aug 2026−$0.74−$1.06−42.8%
May 2026−$0.40−$13.43−3,257.5%
Feb 2026$0.02−$0.11−650.0%
Nov 2025−$0.10$0.05+150.0%

The latest year is open to everyone — the 28 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
Jul 2019
Dec 2018
Sep 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 3, 2026−$0.53$178.1M
Aug 5, 2026−$0.74−$1.06−42.8%$166.3M$176.2M+5.9%
May 6, 2026−$0.40−$13.43−3,257.5%$148.2M$159.9M+7.9%
Feb 25, 2026$0.02−$0.11−650.0%$142.5M$148.9M+4.5%
Nov 4, 2025−$0.10$0.05+150.0%$140.9M$133.0M−5.6%

The latest year is open to everyone — the 28 quarters behind it read with an account.

Sign in
Aug 6, 2025
May 7, 2025
Feb 26, 2025
Nov 12, 2024
Aug 7, 2024
May 8, 2024
Feb 28, 2024
Nov 2, 2023
Aug 3, 2023
May 4, 2023
Mar 8, 2023
Nov 9, 2022
Aug 4, 2022
May 5, 2022
Mar 9, 2022
Nov 15, 2021
Aug 5, 2021
May 6, 2021
Mar 9, 2021
Nov 12, 2020
Aug 6, 2020
May 7, 2020
Mar 12, 2020
Nov 6, 2019
Aug 28, 2019
Jul 25, 2019
Dec 31, 2018
Sep 30, 2018